| Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy MP Hamilton, T Sugio, T Noordenbos, S Shi, PL Bulterys, CL Liu, X Kang, ... New England Journal of Medicine 390 (22), 2047-2060, 2024 | 6 | 2024 |
| Model-based cellular kinetic analysis of SARS-CoV-2 infection: different immune response modes and treatment strategies Z Zhou, Z Zhao, S Shi, J Wu, D Li, J Li, J Zhang, K Gui, Y Zhang, H Mei, ... arXiv preprint arXiv:2101.04477, 2021 | 3 | 2021 |
| Absence of Evidence for Pervasive CAR19 Driven T-Cell Lymphomagenesis Revealed By Comprehensive Genomic Profiling of an Index Tumor. MP Hamilton, T Sugio, T Noordenbos, S Shi, M Diehn, D Gratzinger, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | 2 | 2024 |
| Dynamical modelling of viral infection and cooperative immune protection in COVID-19 patients Z Zhou, D Li, Z Zhao, S Shi, J Wu, J Li, J Zhang, K Gui, Y Zhang, ... PLOS Computational Biology 19 (9), e1011383, 2023 | 2 | 2023 |
| Loss of the OX40 Target in Lymphoma Patients after Combining an Anti-OX40 Agonist Antibody with in Situ Vaccination DK Czerwinski, T Shree, S Haebe, S Shi, SR Long, B Martin, R Levy Blood 142, 3020, 2023 | | 2023 |
| Phase separation in synthetic biology S Shi, Wen S, X Ouyang, P Wei Quantitative Biology 4 (2021, Vol. 9), 378-399, 2021 | | 2021 |
| Evolutionary Dynamics Model of Prostate Cancer and Optimization of Treatment Strategies X Gao, S Shi, F Li Beijing Da Xue Xue Bao 55 (6), 995-994, 2019 | | 2019 |
Fangting LiPeking University在 pku.edu.cn 的电子邮件经过验证
Fangting LiPeking University在 pku.edu.cn 的电子邮件经过验证
Jingpeng ZhangPeking University在 pku.edu.cn 的电子邮件经过验证
Dianjie LiPeking University在 pku.edu.cn 的电子邮件经过验证
Ping “Andy” Wei - 魏平Shenzhen Institute of Advanced Technology在 siat.ac.cn 的电子邮件经过验证